Company profile for Warner Chilcott Company, LLC

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Actavis plc (NYSE: ACT) is a unique specialty pharmaceutical company focused on developing, manufacturing and commercializing high quality affordable generic and innovative branded pharmaceutical products for patients around the world.The Company is an industry leader in product research and development, with one of the broadest brand development pipelines in the pharmaceutical industry, and a leading position in the submissio...
Actavis plc (NYSE: ACT) is a unique specialty pharmaceutical company focused on developing, manufacturing and commercializing high quality affordable generic and innovative branded pharmaceutical products for patients around the world.The Company is an industry leader in product research and development, with one of the broadest brand development pipelines in the pharmaceutical industry, and a leading position in the submission of generic product applications. Actavis has commercial operations in more than 60 countries and operates more than 30 manufacturing and distribution facilities around the world.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Administrative Headquarters Morris Corporate Center III 400 Interpace Parkway ...
Telephone
Telephone
1 (862) 261-7000
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

http://www.reuters.com/article/idUSFit982851?rpc=401&

REUTERS
08 Dec 2016
Valeant brings in Zoetis, Warner Chilcott vet as new CFO
Valeant brings in Zoetis, Warner Chilcott vet as new CFO

22 Aug 2016

// Eric Palmer FIERCE PHARMA

http://www.fiercepharma.com/pharma/valeant-brings-zoetis-warner-chilcott-vet-as-new-cfo

Eric Palmer FIERCE PHARMA
22 Aug 2016
Former Warner Chilcott Executive Acquitted of Kickbacks Charge
Former Warner Chilcott Executive Acquitted of Kickbacks Charge

17 Jun 2016

// Petes Loftus WALL STREET JOURNAL

http://www.wsj.com/articles/former-warner-chilcott-executive-acquitted-of-kickbacks-charge-1466185569

Petes Loftus WALL STREET JOURNAL
17 Jun 2016
Pfizer and Allergan to mull splitting up again in 2018 say CEOs
Pfizer and Allergan to mull splitting up again in 2018 say CEOs

13 Jan 2016

// Dan Stanton+ IN PHARMATECHNOLIGIST

http://www.in-pharmatechnologist.com/Processing/Pfizer-and-Allergan-to-mull-splitting-up-again-in-2018-say-CEOs

Dan Stanton+ IN PHARMATECHNOLIGIST
13 Jan 2016
Pfizer to buy Allergan in $160 billion deal
Pfizer to buy Allergan in $160 billion deal

24 Nov 2015

// Ransdell Pierson REUTERS

http://www.reuters.com/article/2015/11/24/us-allergan-m-a-pfizer-idUSKBN0TB0UT20151124#WfzzwRBLGWbJPBm0.97

Ransdell Pierson REUTERS
24 Nov 2015

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty